GE HealthCare Technologies Inc. Common Stock (GEHC)
Stock · NASDAQ · Health Care
$69.59as of 10/16/2026
Price chart
Active signals
GEHC Signal Track Record
How signals performed across all stocks →What GEHC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 25 | +1.7% | 60% | September 17, 2026 |
| Bollinger Band Breakdown | 17 | +3.1% | 65% | September 3, 2026 |
| 200-Day Moving Average TouchActive now | 17 | -1.1% | 47% | August 26, 2026 |
| Bollinger Band Breakout | 16 | -0.3% | 50% | July 29, 2026 |
| Any 20-session window (baseline) | +0.7% | 53% |
Computed by MarketWall from daily closing prices since October 3, 2023. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About GEHC
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). T…
- Sector
- Health Care
- Industry
- Medical Electronics
- Employees
- 54,000
- Website
- www.gehealthcare.com
Fundamentals
- 1-day range
- $69.5$70.99
- Market cap
- $31.76B
- P/E (trailing)
- 16.01
- P/E (forward)
- 13.00
- EPS (trailing)
- $4.35
- Dividend yield
- 0.16%
- Beta
- 0.84
- Avg. volume
- 3.94M
- Ex-dividend date
- October 23, 2026
- Dividend pay date
- November 13, 2026
How GE HealthCare Technologies Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 4, 2026 · via SEC EDGAR / Finnhub
Forecasts
20 analyst ratings
GE HealthCare Technologies Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- GEHCGE HealthCare Technologies Inc. Common Stock$69.57▼ 1.11%Market cap $31.76BP/E 16.01$58.75$89.77
- PHGKoninklijke Philips N.V. NY Registry Shares$25.74▲ 0.98%Market cap $25.88BP/E 19.62$20.9$27.7
- BFLYButterfly Network Inc. Class A Common Stock$7.25▼ 7.64%Market cap $2.21BP/E —$1.9$10.21
- NNOXNANO-X IMAGING LTD Ordinary Shares$0.453▼ 7.74%Market cap $70.98MP/E —$0.5$4.71
- MBAICheck-Cap Ltd. Ordinary Share$2.75▼ 11.29%Market cap $10.04MP/E 4.99$3$27.44
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| GEHC GE HealthCare Technologies Inc. Common Stock | $31.76B | 16.01 | $69.57 | ▼ 1.11% | $58.75$89.77 |
| PHG Koninklijke Philips N.V. NY Registry Shares | $25.88B | 19.62 | $25.74 | ▲ 0.98% | $20.9$27.7 |
| BFLY Butterfly Network Inc. Class A Common Stock | $2.21B | — | $7.25 | ▼ 7.64% | $1.9$10.21 |
| NNOX NANO-X IMAGING LTD Ordinary Shares | $70.98M | — | $0.453 | ▼ 7.74% | $0.5$4.71 |
| MBAI Check-Cap Ltd. Ordinary Share | $10.04M | 4.99 | $2.75 | ▼ 11.29% | $3$27.44 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- BTIG Maintains Buy on GE HealthCare Techs, Lowers Price Target to $75benzinga · 10/12/2026
- 2 Nasdaq 100 Stocks to Own for Decades and 1 We QuestionYahoo · 10/9/2026
- Why GE HealthCare (GEHC) Is Doubling Down on Pharmaceutical Diagnostics?Yahoo · 10/9/2026
- GE HealthCare: M&A And Execution To Drive A Value Re-RatingSeekingAlpha · 10/9/2026
- 2 Mid-Cap Stocks to Keep an Eye On and 1 We QuestionYahoo · 10/8/2026
- Intel downgraded, Marvell upgraded: Wall Street's top analyst callsYahoo · 10/7/2026
- GE HealthCare to announce third quarter 2026 results on October 28, 2026Yahoo · 10/7/2026
- Here Are Wednesday’s Top Wall Street Analyst Research Calls: Abbott Laboratories, AppFolio, Delek US Holdings, Flutter Entertainment, Honeywell Aerospace, Intuitive Surgical, Marvell, NetApp, and MoreYahoo · 10/7/2026
- Barclays Initiates Coverage On GE HealthCare Techs with Overweight Rating, Announces Price Target of $85Benzinga · 10/7/2026
Insider Activity
Insider Actions →- William K. Grogan · September 14, 2026 · Grant31.9K
- William K. Grogan · September 14, 2026 · Grant12.8K
- William K. Grogan · September 14, 2026 · Grant62.3K
- Estrampes Catherine · September 3, 2026 · Tax Withholding508 @ $70.56
- Philip Rackliffe · September 3, 2026 · Tax Withholding798 @ $70.56
- Taha Kass-Hout · September 3, 2026 · Tax Withholding1.5K @ $70.56
- George A. Newcomb · September 3, 2026 · Tax Withholding112 @ $70.56
- Kevin Michael O'Neill · September 3, 2026 · Tax Withholding718 @ $70.56
- Adam Y. Holton · September 3, 2026 · Tax Withholding673 @ $70.56
- Frank R. Jimenez · September 3, 2026 · Tax Withholding1.5K @ $70.56
- Peter J. Arduini · September 3, 2026 · Tax Withholding6.3K @ $70.56
- Philip Rackliffe · September 1, 2026 · Tax Withholding340 @ $71.23
- Philip Rackliffe · September 1, 2026 · Tax Withholding226 @ $71.23
- Philip Rackliffe · September 1, 2026 · Tax Withholding290 @ $71.23
- Taha Kass-Hout · September 1, 2026 · Tax Withholding1.3K @ $71.23
Institutional Ownership
March 31, 2026
- Total shares held
- 359.86M
- Total value held
- $24.81B
- Institutional holders
- 1241
- Unknown35.98M
- Unknown31.31M
- Unknown28.86M
- Unknown21.11M
- Unknown20.54M
- Unknown15.59M
- Unknown12.40M
- Unknown11.88M
- Unknown9.97M
- Unknown7.74M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
GEHC Secures CE Mark for MINItrace Magni Cyclotron
GE HealthCare (GEHC) has received CE approval for its MINItrace Magni cyclotron, expanding its PETtrace™ solid‑target platform to include copper‑64. The approval follows research showing its End‑tial Control software can reduce fresh gas flow in anesthesia settings. In addition, HeartBeam has joined a European consortium to develop at‑home ECG monitoring for early detection of acute coronary syndrome. These developments broaden GEHC’s product portfolio and support its investment narrative.
GEHC Secures CE Mark for MINItrace Magni Cyclotron. GE HealthCare (GEHC) has received CE approval for its MINItrace Magni cyclotron, expanding its PETtrace™ solid‑target platform to include copper‑64. The approval follows research showing its End‑tial Control software can reduce fresh gas flow in anesthesia settings. In addition, HeartBeam has joined a European consortium to develop at‑home ECG monitoring for early detection of acute coronary syndrome. These developments broaden GEHC’s product portfolio and support its investment narrative.